Tesla stock extends gains after the electric-vehicle maker’s market cap closes above $1 trillion for the first time since ...

Humana's stock has fallen over 30% due to rising healthcare utilization and CMS pushing back on insurer profits, impacting MA ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

During the annual enrollment period through December 7th, individuals eligible for Medicare can choose Medicare Advantage or ...

Despite reports this fall that the two payers had reopened merger talks, Cigna plans to use excess cash to buy back its ...

The insurer said it doesn’t expect earnings growth next year due to significant investments it plans to make to boost MA ...

Healthcare investors are desperate for big returns in a second Trump term. But his health policy proposals are making them ...

Humana Stock Is Tumbling. Cigna Won't Pursue the Health Insurer. Investors have long appeared skeptical about a potential merger between the two health insurers. AbbVie Stock Tumbles on Failed ...

As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of ...

Humana Inc (HUM) reports robust growth and strategic investments, while addressing challenges in drug costs and membership ...